Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

NCT07410039 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica Spectrum Disorder Attack

Interventions

DRUG: Eculizumab+IVMP
DRUG: IVIG+IVMP
DRUG: IVMP

Sponsor

Chinese PLA General Hospital